Annovis Bio (ANVS) Short Interest Ratio & Short Volume

Short interest is the volume of Annovis Bio shares that have been sold short but have not yet been closed out or covered. As of October 15th, investors have sold 1,360,000 shares of ANVS short. Learn More on Annovis Bio's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ANVS shares currently have a short interest ratio of 6.0. Learn More on Annovis Bio's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Annovis Bio: Belvedere Trading LLC, and Affinity Asset Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Annovis Bio saw a increase in short interest in the month of October. As of October 15th, there was short interest totaling 1,360,000 shares, an increase of 12.4% from the previous total of 1,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Annovis Bio: COMPASS Pathways plc (8.50%), Biomea Fusion, Inc. (29.18%), 4D Molecular Therapeutics, Inc. (18.26%), GH Research PLC (5.85%), C4 Therapeutics, Inc. (9.59%), Cartesian Therapeutics, Inc. (18.37%), Organogenesis Holdings Inc. (13.25%), ProKidney Corp. (14.01%), Esperion Therapeutics, Inc. (18.23%), Taysha Gene Therapies, Inc. (10.10%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks.

Short selling ANVS is an investing strategy that aims to generate trading profit from Annovis Bio as its price is falling. ANVS shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Annovis Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ANVS, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ANVS, twice per month. The most recent reporting period available is October, 15 2024.